BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 23396738)

  • 41. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
    Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Ikeda K; Kawamura Y; Kobayashi M; Kominami Y; Fujiyama S; Sezaki H; Hosaka T; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Dig Dis Sci; 2017 Oct; 62(10):2932-2942. PubMed ID: 28884320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Fang KC; Su CW; Chiou YY; Lee PC; Chiu NC; Liu CA; Chen PH; Kao WY; Huang YH; Huo TI; Hou MC; Lin HC; Wu JC
    Eur Radiol; 2017 Jun; 27(6):2600-2609. PubMed ID: 27678133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.
    Cho JY; Choi MS; Lee GS; Sohn W; Ahn J; Sinn DH; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW
    Clin Mol Hepatol; 2016 Dec; 22(4):477-486. PubMed ID: 28081587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of sustained virological response to interferon therapy for hepatitis C to the hepatectomy for primary hepatocellular carcinoma.
    Tsujita E; Maeda T; Kayashima H; Harada N; Tsutsui S; Matsuda H; Kinjo N; Ikeda Y; Morita M; Ishida T
    Hepatogastroenterology; 2015; 62(137):157-63. PubMed ID: 25911888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria.
    Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Lin HC; Chiou YY; Lee FY; Huo TI
    Ann Surg Oncol; 2013 Jun; 20(6):2035-42. PubMed ID: 23306955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
    Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
    J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.
    Rui S; Yan J; Zhang H; Wang Z; Zhou W
    Medicine (Baltimore); 2017 Jul; 96(30):e7608. PubMed ID: 28746212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
    Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
    Xiao GQ; Yang JY; Yan LN
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma.
    Brahmania M; Ahmed O; Kelley M; Wong D; Kowgier M; Khalili K; Beecroft R; Renner EL; Shah H; Feld J; Janssen HLA; Sherman M
    Ann Hepatol; 2017; 16(5):765-771. PubMed ID: 28809734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second hepatectomy for recurrent hepatocellular carcinoma achieved sustained virological response to interferon therapy for hepatitis C.
    Tsujita E; Yamashita Y; Takeishi K; Maeda T; Takaki S; Mori N; Aisaka Y; Furukawa Y; Shirabe K; Ishida T; Maehara Y
    Hepatogastroenterology; 2013; 60(128):2048-54. PubMed ID: 24088310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.
    Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Wang CC; Li WF; Lin CY
    Updates Surg; 2024 Jun; 76(3):879-887. PubMed ID: 38582796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
    Shen J; Liu J; Li C; Wen T; Yan L; Yang J
    Dig Dis Sci; 2018 Jul; 63(7):1962-1969. PubMed ID: 29736828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery.
    Kondo K; Chijiiwa K; Funagayama M; Kai M; Otani K; Ohuchida J
    J Gastrointest Surg; 2008 Mar; 12(3):468-76. PubMed ID: 17999119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival.
    Groeschl RT; Hong JC; Christians KK; Turaga KK; Tsai S; Pilgrim CH; Gamblin TC
    HPB (Oxford); 2013 Oct; 15(10):794-802. PubMed ID: 23782341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.